Match. Apply. Get paid. The simplest way to participate in paid clinical research.

Compensation is for time and inconvenience, not income.

Arctuva

Browse Studies About FAQ

Arctuva

Match. Apply. Get paid. The simplest way to participate in paid clinical research.

Product

Browse Studies How it Works Verification Arctuva Pro For Sponsors

Company

About Contact FAQ

Legal

Privacy Terms of Service Security Accessibility Transparency Report

Compensation is for time and inconvenience, not income.

Browse Studies — Arctuva | Arctuva

Browse studies

Find your next paid study

3 recruiting studies matching your filters

Newest first Highest paying

Filters

Condition

Location

Phase

Min compensation ($)

Max compensation ($)

Phase 2

Corneal Crosslinking for Treatment of Progressive Keratoconus or Ectasia: Randomized Comparison of Pulsed vs. Non-pulsed Treatment

This randomized study compares 2 variations of corneal crosslinking for treatment of keratoconus or corneal ectasia.

KeratoconusCorneal Ectasia

~Estimated

~$10 – $7,500

Price Vision GroupNCT07841470

Phase 4

Outcomes of Corneal Tissue Addition for Keratoplasty (CTAK) in Patients With Ectatic Corneas

Measuring quality of vision and quality of life outcomes using a validated questionnaire in participants undergoing CTAK surgery for corneal ectasia

KeratoconusCorneal Ectasia

~Estimated

~$10 – $6,250

Stanford UniversityNCT07474870

Phase 2

Safety and Effectiveness of the PXL-Platinum 330 System for Corneal Cross-Linking in Eyes With Corneal Ectasia

To evaluate the safety and effectiveness of the PXL Platinum 330 system for performing corneal cross-linking (CXL) for the treatment of ectatic disorders.

KeratoconusPellucid Marginal Corneal DegenerationCorneal Ectasia

~Estimated

~$10 – $7,500

Goodman Eye CenterNCT04094090